🇺🇸 Fondaparinux background and low dose heparin in United States

Fondaparinux background and low dose heparin (Fondaparinux background and low dose heparin) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Fondaparinux background and low dose heparin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Fondaparinux background and low dose heparin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Fondaparinux background and low dose heparin in United States?

GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.